Legal Representation
Attorney
Jong Park
USPTO Deadlines
Next Deadline
1517 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-01-02)
Due Date
January 02, 2030
Grace Period Ends
July 02, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
26 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 2, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jan 2, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 17, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 17, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 27, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 8, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 29, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 29, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 26, 2023 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 14, 2023 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Mar 30, 2023 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Mar 30, 2023 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Mar 30, 2023 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Sep 30, 2022 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Sep 30, 2022 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Sep 30, 2022 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Aug 30, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 29, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 29, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 26, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 26, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 26, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 19, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 7, 2021 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Oct 6, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 21, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cells; medicines for human purposes, namely, pharmaceutical preparations for the treatment of cancer or immune disease; living cells for medical purposes; living cells for veterinary purposes; cells, namely, chimeric antigen receptor T-cell (CAR-T), for medical purposes; pharmaceutical preparations for activating cellular function; preparations of microorganisms for medical purposes; biological preparations for medical or veterinary purposes, namely, pharmaceutical preparations for the treatment of cancer or immune disease; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for health care, namely, pharmaceutical preparations for the treatment of cancer or immune disease; vaccines; colostral, murine, chimeric, humanized, human, monoclonal, and polyclonal antibodies for veterinary purposes; antibodies for medical purposes; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer or immune disease; pharmaceutical preparations for the treatment of cancers with T cells
Class 042
Product development in the field of cell therapy; research relating to pharmaceuticals; pharmaceutical drug development services; research and development of pharmaceuticals; research and development of vaccines; cell separation research services; biomedical research services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; genetic testing, namely, biological information check, for medical research use; product development, namely, biologics development; research in the field of biologics; biological analysis; biological research; research in the field of gene analysis; genetic research; consultancy in the field of analysis of biology sequence processing for medical research purposes; multiple nucleotide sequence analysis for scientific research purposes; DNA sequence analysis for scientific research purposes
Additional Information
Design Mark
The mark consists of a circle design having three sections with colors of purple, orange and red and the word of "Karratio" in red.
Color Claim
The color(s) purple, orange and red is/are claimed as a feature of the mark.
Classification
International Classes
005
042